Xpansion
Commercial- Indications
- Wounds, Skin grafting
Company intelligence / Profile preview
Applied Tissue Technologies is an advanced wound care and regenerative medicine company founded in 2000 and based in Hingham, Massachusetts. The company is best known for its FDA-cleared Platform Wound Dressing (PWD), a novel negative pressure wound therapy (NPWT) system that eliminates the need for traditional foam or gauze fillers. Its product portfolio also includes the Xpansion Micro-Autografting Kit, which facilitates efficient outpatient skin grafting for chronic and traumatic wounds. The company has a long-standing research relationship with the U.S. Department of Defense, focusing on solutions for prolonged field care and military medical applications. In December 2025, Applied Tissue Technologies' business assets were acquired by New Horizon Medical Solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Applied Tissue Technologies.